Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2003
05/22/2003WO2003042368A2 Methods of expressing lim mineralization protein in non-osseous cells
05/22/2003WO2003042366A2 A novel saitohin gene and uses of same
05/22/2003WO2003042364A2 Identifying and controlling the growth of estrogen-responsive cells
05/22/2003WO2003042363A2 Eit-6, a polypeptide encoded by an estrogen regulated gene
05/22/2003WO2003042362A2 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
05/22/2003WO2003042361A2 Production of adeno-associated virus in insect cells
05/22/2003WO2003042359A2 Histamine receptor h3 polynucleotides
05/22/2003WO2003042357A2 Enzymes
05/22/2003WO2003042356A2 Pttg knockout rodent as a model to study mechanisms for various physiological phenomena, including diabetes
05/22/2003WO2003042354A2 Abrogen polypeptides, nucleic acids encoding them and methods for using them to inhibit angiogenesis
05/22/2003WO2003042249A2 Peptide purification by means of metal ion affinity chromatography
05/22/2003WO2003042246A2 Inhibitors of the notch signalling pathway for use in the treatment of cancer
05/22/2003WO2003042245A2 Growth hormone variations in humans and their uses
05/22/2003WO2003042244A2 Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts
05/22/2003WO2003042243A2 Immunogenic alk (anaplastic lymphoma kinase) peptides
05/22/2003WO2003042242A1 Zinc-finger protein interacting with the mch receptor
05/22/2003WO2003042240A2 Polypeptides of pseudomonas aeruginosa
05/22/2003WO2003042239A1 Peptides inhibiting signaling by ras-like gtpases
05/22/2003WO2003042238A2 Estrogen induced transcription modulating protein met
05/22/2003WO2003042235A2 Extended native chemical ligation of three or more peptide fragments
05/22/2003WO2003042233A2 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry
05/22/2003WO2003042232A2 Crystals and structures of yiim proteins
05/22/2003WO2003042226A2 Single nucleotide polymorphisms in gh-1
05/22/2003WO2003041738A1 Treatment of metabolic disorders with xitar agonists and antagonists
05/22/2003WO2003041734A1 Salmonella vaccine
05/22/2003WO2003041659A2 Method and identification of downstream mrna ligands to fmrp and their role in fragile x syndrome and associated disorders
05/22/2003WO2003041560A2 Compounds and methods for treatment and diagnosis of chlamydial infection
05/22/2003WO2003041496A1 Transgenic animal
05/22/2003WO2003041495A1 Chimeric nonhuman animal
05/22/2003WO2003031631A8 Modification of plant responses to salt
05/22/2003WO2003027255A3 Anti-fusion assay
05/22/2003WO2003025145A3 Nanomachine compositions and methods of use
05/22/2003WO2003020763A3 Soluble t cell receptor
05/22/2003WO2003018818A8 Method and means for modulating plant cell cycle proteins and their use in plant cell growth control
05/22/2003WO2003018066A3 A murine genomic polynucleotide sequence encoding a g-protein coupled receptor and methods of use therefor
05/22/2003WO2003016497A3 Molecules for disease detection and treatment
05/22/2003WO2003012089A3 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof
05/22/2003WO2003006653A8 Mycoplasma spp. a39
05/22/2003WO2003003904A3 Coactivators in the diagnosis and treatment of breast cancer
05/22/2003WO2002102987A3 Methods and compositions based on protein interactions with mastermind
05/22/2003WO2002102974A3 Mutant proteins, high potency inhibitory antibodies and fimch crystal structure
05/22/2003WO2002102836A3 Moraxella (branhamella) catarrhalis antigens
05/22/2003WO2002097103A3 Constitutive plant promotor
05/22/2003WO2002090550A3 Method for preparing recombinant poxvirus
05/22/2003WO2002085298A3 Method for detecting breast cancer cells
05/22/2003WO2002081625A3 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
05/22/2003WO2002079756A3 Novel molecules of the multi-drug and toxin efflux (mate) protein family and uses thereof
05/22/2003WO2002072754A3 Mva expressing modified hiv envelope, gag, and pol genes
05/22/2003WO2002072036A3 Compositions and methods comprising west nile virus polypeptides
05/22/2003WO2002068653A3 Tri-hybrid melanoma antigen
05/22/2003WO2002068466A3 Hypoxia-regulated genes
05/22/2003WO2002059369A3 Compositions and methods for the treatment of diseases related to faulty cholesterol regulation
05/22/2003WO2002058627A3 A cystic fibrosis transmembrane-conductance regulator (cftr)-membrane translocation sequence fusion protein (cftr-mts) as a therapeutic agent
05/22/2003WO2002056831A3 Immunogenic proteoliposomes, and uses thereof
05/22/2003WO2002053740A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/22/2003WO2002046768A3 Proteins, genes and their use for diagnosis and treatment of chronic asthma
05/22/2003WO2002044722A3 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
05/22/2003WO2002044215A3 Hybrid antibodies
05/22/2003WO2002036629A3 Regulation of human serotonin receptor precursor
05/22/2003WO2002031180A3 Flea peritrophin nucleic acid molecules, proteins and uses thereof
05/22/2003WO2002029050A3 Regulation of human secretin receptor-like gpcr
05/22/2003WO2002026780A3 Paad domain-containing polypeptides, encoding nucleic acids, and methods of use
05/22/2003WO2002024743A3 55063, a human nmda family member and uses thereof
05/22/2003WO2002023202A3 Method to identify antibody targets based on mass spectrometry (maldi-tof)
05/22/2003WO2002022807A3 Dermatophagoides nucleic acid molecules, proteins and uses thereof
05/22/2003WO2002022776A9 Human coagulation factor vii variants
05/22/2003WO2002010389A3 Human ion channel proteins and polynucleotides encoding the same
05/22/2003WO2001086003A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human lung
05/22/2003WO2001072774A3 Cell cycle progression proteins
05/22/2003WO2001070941A9 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis
05/22/2003US20030097690 For regulating expression of heterologous nucleotide sequences in a plant
05/22/2003US20030097689 Seed-preferred promoters from end genes
05/22/2003US20030097687 Herbicide tolerant phenotype with an agronomic performance, genetic stability and adaptability to different genetic backgrounds equivalent to the non-transformed cotton line in the absence of weed pressure
05/22/2003US20030097685 Lipid metabolism regulators in plants
05/22/2003US20030097683 For transformation of a host organism with a foreign RNA
05/22/2003US20030097675 Cell cycle stress-related proteins and methods of use in plants
05/22/2003US20030097673 Enhanced accumulation of trehalose in plants
05/22/2003US20030097672 Transforming plant cell with a nucleic acid construct containing a polynucleotide encoding gai gene, regulatory sequence, and transcription termination sequence; regenerating plant from plant cell; expression of gai gene inhibits pollen
05/22/2003US20030097671 Inhibition of betaarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
05/22/2003US20030097670 For producing and isolating homogeneous proteins
05/22/2003US20030097669 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5
05/22/2003US20030097668 Compositions and methods for the treatment and diagnosis of cardiovascular disease
05/22/2003US20030097667 For therapy of Alzheimers disease, diagnosis
05/22/2003US20030097666 Novel human genes and gene expression products:II
05/22/2003US20030096985 Small and cysteine rich antifungal defensin and thionin-like protein genes highly expressed in the incompatible interaction
05/22/2003US20030096984 Dna molecules encoding ligand gated ion channels from dermacentor variabilis
05/22/2003US20030096983 Polynucleotide encoding a gene conferring resistance to bacillus thuringiensis toxins
05/22/2003US20030096982 Nucleotide sequences coding polypeptide for use in the treatment of immunological, reproductive and liver disorders
05/22/2003US20030096977 Antibody against human interleukin-5 receptor alpha chain
05/22/2003US20030096974 Transgenically produced antithrombin III
05/22/2003US20030096973 Recombinant collagens and derived proteins produced by plants, methods of obtaining such and their uses
05/22/2003US20030096972 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096971 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096970 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/22/2003US20030096969 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/22/2003US20030096968 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/22/2003US20030096967 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096966 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/22/2003US20030096965 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096964 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders